SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001250853-16-000137
Filing Date
2016-03-30
Accepted
2016-03-30 19:01:34
Documents
1
Period of Report
2016-03-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1488
  Complete submission text file 0001250853-16-000137.txt   3077
Mailing Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120
Business Address 112 WEST 34TH STREET 17TH FLOOR NEW YORK NY 10120 212-946-4826
Lion Biotechnologies, Inc. (Issuer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 112 WEST 34TH STREET, 17TH FLOOR NEW YORK NY 10120
Business Address
Lotze Michael (Reporting) CIK: 0001670549 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36860 | Film No.: 161541304